Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Para-aminobenzoic acid (PABA) and Sulfanilamide

Research Papers that Mention the Interaction

Recently, as the result of a series of investigations with growing animals and micro-organisms, the findings of Woods (8) on the interference of p-aminobenzoic acid with sulfanilamide action have been extended by Woolley (9).
Cancer research  •  1946  |  View Paper
Sulfanilamide growth inhibition was reversed competitively by PABA and by very high concentrations of folic acid.
The Journal of protozoology  •  1968  |  View Paper
Findlay (1940), feeding 10 mg sulfanilamide and 10 mg PABA suspended in gum acacia to mice, found that PABA antagonized the chemotherapeutic action of sulfanilamide for the LGV virus injected intracerebrally.
Journal of bacteriology  •  1949  |  View Paper
Inhibition of growth by sulphanilamide can be reversed by p-aminobenzoic acid.
The Biochemical journal  •  1966  |  View Paper
The effectiveness of p-aminobenzoic acid (PABA) in overcoming sulfanilamide (SA) growth inhibition of Escherichia coli was explained on the basis that PABA was an essential metabolite and that SA interfered with -its utilization by the cell (Woods, 1940).
Journal of bacteriology  •  1957  |  View Paper
Increasing levels of sulfanilamide in the medium competitively inhibit the utilization of PABA for growth of L. arabinosus and decrease the amount of free and combined FA compounds formed.
Archives of biochemistry and biophysics  •  1951  |  View Paper
An intensive search for antagonists of most of the known metabolites began in 1940 after Woods' announced that the chemotherapeutic properties of sulfanilamide were due to competition with the structurally related metabolite, p-aminobenzoic acid.
Annals of the New York Academy of Sciences  •  1950  |  View Paper
Growth inhibition by the higher concentrations of PABA is competitively antagonized by SA.
Journal of bacteriology  •  1950  |  View Paper
The report of Woods’ in I940 that the bacteriostatic action of sulfanilamide was competitively prevented by p-aminobenzoic acid , which was not known a t the time to have a biological function, prompted a widespread search for chemotherapeutic agents among compounds structurally related to metabolites.
Annals of the New York Academy of Sciences  •  1950  |  View Paper
This, according to the theory of Woods (1940) that p-aminobenzoic acid is a specific antagonist for sulfanilamide , classified the bacteriostatic action of 2-Cl-PAB as sulfonamide activity.
Journal of bacteriology  •  1947  |  View Paper
Show More